WFWei Feng

Wei Feng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wei Feng has a total of 82 co-authors. Here are the top co-authors by number of shared publications:

  • Kun-Peng Li

    School of Exercise and Health, Shanghai University of Sport, Shanghai, China

    5 shared publications
  • Tianjun Zhai

    School of Acupuncture, Moxibustion and Tuina (School of Rehabilitation Medicine), Anhui University of Chinese Medicine

    5 shared publications
  • Fei Li

    Department of Rehabilitation Medicine, Tongji University Affiliated Shanghai Fourth People's Hospital

    3 shared publications
  • Hongyuan Lu

    Shanghai University of Traditional Chinese Medicine School of Rehabilitation Science, Shanghai, China

    3 shared publications
  • Zengqiao Zhang

    Department of Rehabilitation, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China

    3 shared publications
  • Fengyan Jiang

    Chinese Medicine Department, Hangzhou West Lake District Beishan Street Community Health Service Center, Hangzhou, Zhejiang, China

    2 shared publications

Latest Publications

  • Open Access

    “Internal carotid artery-type cervical spondylosis” is not supported as an independent subtype: a perspective on diagnostic classification and clinical differentiation

    by Tianjun Zhai, Yeping Chen, Wei Feng, Hui Zhang

    Cervical spondylosis is a common degenerative disorder, yet its diagnostic boundaries may be inappropriately expanded when nonspecific symptoms such as dizziness coexist with age-related cervical imaging changes. This Perspective evaluates the hypothetical concept of “internal carotid artery-type cervical spondylosis” and whether it qualifies as an independent clinical subtype. Using an adapted validity–utility framework, the proposed entity was assessed according to five criteria: a specific anatomical relationship, a reproducible pathophysiological mechanism, a recognizable clinical phenotype, supportive imaging or ancillary evidence, and independent diagnostic utility. Unlike the vertebral artery, the cervical internal carotid artery has no consistent anatomical relationship with routine degenerative cervical structures. Rare bony–carotid conflicts may occur, but these are anomaly-driven vascular lesions and do not establish a general degenerative subtype. Nonspecific dizziness does not localize pathology to the internal carotid artery, whereas focal anterior-circulation symptoms are better explained by established carotid or cerebrovascular disorders. Clinically, transient monocular visual loss, aphasia, hemiparesis, focal cortical deficits, or new unilateral head or neck pain with partial Horner syndrome or cranial nerve findings should prompt urgent vascular or stroke-oriented evaluation. Current evidence therefore does not support “internal carotid artery-type cervical spondylosis” as an independent subtype. Maintaining clear diagnostic boundaries may reduce mislabeling and improve patient safety.

  • Open Access

    Efficacy of Liuzijue in Improving Respiratory Muscle Dysfunction in Chronic Obstructive Pulmonary Disease: Protocol for a Randomized Controlled Trial

    by Yiting Ni, Wei Feng, Wangtao Cai, Yuxin Sun, Min Cao, Juhan Chen, Jian Li

    Background: Chronic obstructive pulmonary disease (COPD) is a prevalent chronic lung disease, and respiratory muscle dysfunction is one of its key pathogenic mechanisms. Liuzijue, a traditional Chinese health exercise, has been widely applied in COPD rehabilitation, showing benefits in improving pulmonary function and quality of life. However, clinical evidence regarding its specific effects on respiratory muscle function remains insufficient. Objective: This study describes the protocol of a randomized controlled trial designed to evaluate the effects of Liuzijue exercise on respiratory muscle function and functional outcomes in patients with COPD. Methods: This study adopts a randomized controlled trial design, with participants randomly assigned to either a control group or a Liuzijue group. The control group receives standardized pharmacological treatment, while the Liuzijue group receives the same pharmacological treatment combined with Liuzijue intervention. The coprimary outcome measures are the 6-minute walk test and surface electromyography of the respiratory muscles. Secondary outcome measures include pulmonary function tests and respiratory questionnaires. Exploratory outcome measures include isokinetic strength testing of the core muscle groups and kinematic analysis. Results: As of manuscript submission, this trial has received ethical approval (reference number: CHEC2025-149) and secured funding in May 2024. Participant recruitment began on August 1, 2025, and has enrolled 15 participants in the control group and 8 participants in the Liuzijue group to date. Recruitment is expected to be completed by September 2026, followed by data collection until December 2026, with data analysis planned for January 2027 and the final results expected to be prepared and submitted for publication in spring 2027. Conclusions: This study is one of the first rigorously designed clinical trials to investigate the effects of Liuzijue on improving respiratory muscle function in patients with COPD, aiming to provide reliable clinical evidence for its efficacy in the rehabilitation of respiratory muscle function in this population.

  • Combining Collagenase Injections with Exercise-Induced Mechanical Overload: A Mouse Model Simulating Overload Stress Injury Knee Osteoarthritis

    by Zeng-Qiao Zhang, Jie Li, Tian-Jun Zhai, Kun-Peng Li, Rui-Ren Wu, Wu Wang, Wu-Quan Sun, Wei Feng

    Knee osteoarthritis (KOA) is a multifactorial degenerative joint disease driven by the complex interplay of biological tissue degradation and sustained mechanical overload. conventional surgical animal models often induce trigger post-traumatic joint destruction, which fails to accurately replicate the gradual and cumulative pathogenesis of human degenerative KOA. To bridge this translational gap, the present study establishes a novel and reproducible mouse model simulating overload stress-induced KOA by synergizing mild enzymatic cartilage degradation with sustained mechanical loading. Specifically, standardized intra-articular injections of type II collagenase were paired with daily mechanical overexertion via a strictly calibrated rotator-type fatigue apparatus over a four-week period. The efficacy of this dual-factor intervention was validated using comprehensive behavioral, histological, and molecular analyses. Automated gait analysis revealed severe locomotor deficits in the combined group. These were characterized by significant reductions in stride length, stride width, and peak stance paw area. Histomorphological evaluations using safranin O-fast green staining confirmed these functional deficits, a showing progressive cartilage structural damage, surface defects, and significantly elevated Osteoarthritis Research Society International (OARSI) scores that faithfully mirror the pathological hallmarks of early-to-mid stage human KOA. Furthermore, immunohistochemical evaluations demonstrated marked upregulation of the mechanosensitive channel Transient Receptor Potential Vanilloid 4 (TRPV4) and concurrent reduction in the crucial matrix protein Collagen Type II Alpha 1 (COL2A1) in articular chondrocytes. By integrating localized joint instability with controlled mechanical stress, this minimally invasive strategy avoids the acute trauma associated with surgical models. This protocol establishes a clinically relevant experimental platform for tracking dynamic molecular mechanisms, evaluating chronic pain phenotypes, and testing long-term therapeutic interventions for early-stage osteoarthritis.

  • Open Access

    Mckenzie therapy plus simplified Wuqinxi exercise for improving lumbar spine motor function in chronic low back pain: a randomized controlled trial protocol

    by Fei Li, Yanjun Cao, Wei Feng

    Background: Chronic low back discomfort may result in functional restrictions that can be incapacitating and cause disruptions to family life. McKenzie therapy (MT) can reduce pain by improving the functional structure of the lumbar spine through exercise and posture, while the simplified Wuqinxis (WQXs) can play a dual role in adjusting physical form and mental state as a traditional Chinese medicine exercise. This study aims to combine the concepts of the two therapies, to develop a more effective and easy exercise prescription for the prevention and treatment of lower back pain, and to explore the biomechanical effects and clinical efficacy. Methods and analysis: A randomized controlled trial will be conducted to compare the efficacy of WQXs with or without MT on patients with chronic low back pain. A total of 74 patients will be randomly assigned to an experimental group (MT and WQXs) and a control group (WQXs). Lumbar range of motion and health-related quality of life in patients with chronic low back pain will be assessed using the range of motion scale, visual analogue scale, and the SF-36 scale. Additionally, surface electromyography (sEMG) and isokinetic muscle strength testing will be employed to evaluate the mechanical properties of the core muscles in the lumbopelvic region. Consider a 20% dropout rate, 74 cases will be gathered in total, taking into account a 20% dropout rate. Results: to ascertain whether the exercise prescription combining the two therapies is effective for treating chronic low back pain. Clinical Trial Registration: Chinese Clinical Trial Registry, identifier ChiCTR2300075499.

  • Open Access

    A novel phase-difference transcranial alternating current stimulation system enables precise dual-site neuromodulation

    by Ruiren Wu, Ying Feng, Jiali Wu, Jingjing Zhang, Wei Feng, Cong Wang, Chunlei Shan

    Precise modulation of large-scale brain networks requires neuromodulation technologies capable of delivering frequency-locked stimulation with accurate and stable inter-regional phase control. However, conventional transcranial alternating current stimulation (tACS) systems generally lack robust dual-channel phase regulation and are rarely validated under realistic biological impedance conditions. Here, we present a novel phase-difference tACS system (PD-stim) designed to deliver programmable, high-precision phase offsets between stimulation targets. We performed a comprehensive engineering and in vivo validation of PD-stim, assessing biological impedance stability, waveform fidelity, amplitude stability, and phase-delivery accuracy. Impedance measurements obtained from the medial prefrontal cortex and hippocampus of rats demonstrated stable frequency-dependent profiles during stimulation. Benchmark comparisons against a clinically approved tACS device revealed comparable waveform fidelity and amplitude stability under both a standardised resistive load and in vivo recording conditions. Using simultaneous dual-channel oscilloscope recordings, PD-stim consistently generated stable sinusoidal waveforms with high phase-delivery accuracy across theta (8 Hz), beta (20 Hz), and gamma (40 Hz) frequency bands, under both biological and resistive conditions. Together, these results establish PD-stim as a precise, stable, and biologically robust dual-site neuromodulation platform that overcomes key technical limitations of existing tACS systems. This work provides a rigorously validated engineering framework for future mechanistic investigations of phase-specific modulation in distributed brain networks, while not addressing functional or therapeutic outcomes.

  • Open Access

    Cortical-multifidus paired associative stimulation for improving motor function in patients with chronic low back pain: study protocol for a randomised controlled trial

    by Hongyuan Lu, Quanwei Shao, Ji Guo, Zheng Huang, Yan-Jun Cao, Fei Li, Wenyao Li, Weiyi Xiong, Kun-Peng Li, Wei Feng

    Introduction Chronic low back pain (CLBP) is characterised by multifaceted pathophysiology involving both central sensitisation and peripheral dysfunction. Conventional therapies often fail to address this complexity due to their unidimensional targets. Paired associative stimulation (PAS), a dual-target neuromodulatory approach that combines central and peripheral interventions, has demonstrated efficacy in enhancing motor recovery post-stroke by synchronously inducing corticospinal plasticity and peripheral neuromuscular adaptation. Building on this paradigm, we propose a novel combined primary motor cortex (M1) and multifidus muscle stimulation protocol. The intervention pairs transcranial magnetic stimulation over M1 with peripheral magnetic stimulation targeting the multifidus muscle, hypothesising that temporally coordinated central and peripheral stimulation will synergistically enhance the corticospinal drive to the lumbar spine and restore multifidus neuromuscular control, thereby alleviating pain and improving functional capacity in CLBP. Methods and analysis This study will enrol 82 individuals diagnosed with CLBP between 18 and 65 years of age. Study participants will undergo randomisation into two parallel groups: the experimental arm receiving active PAS therapy (n=41) and the control arm receiving sham PAS treatment (n=41). The intervention protocol consists of 20 treatment sessions delivered across a 4-week timeframe, with participants attending five sessions weekly. Assessment time points are scheduled at study entry (baseline) and 4, 8 and 12 weeks following intervention initiation. The study’s primary outcome is the Oswestry Disability Index (ODI). Secondary outcomes encompass the Visual Analog Scale (VAS), Short-form McGill Pain Questionnaire (SF-MPQ), Short Form 36 Health Survey (SF-36), Pain Catastrophizing Scale (PCS), and functional magnetic resonance imaging (fMRI). Data analysis will adhere to the intention-to-treat methodology. Between-group comparisons across temporal measurement points will employ mixed-effects modelling approaches. Ethics and dissemination Ethical approval for the research protocol was obtained from the Ethics Committee of Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine (approval number: 2025-K-45), with trial registration completed in the China Clinical Trial Registry on 27 April 2025. On study completion, findings will be prepared for submission to peer-reviewed academic publications. Trial registration number ChiCTR2500101574.


  • Open Access

    Blood flow restriction training combined with muscle energy technology for upper limb functional recovery in poststroke spasticity: a randomised controlled trial protocol at a tertiary hospital in Jiaxing, China

    by Li Yu, Peng-Fei Xue, Li-Feng Qian, Wei Feng, Qing Yao

    Introduction: Stroke is a leading cause of death and disability worldwide, with spasticity affecting 4%–42.6% of stroke survivors. Prolonged spasticity can lead to pain, restricted joint mobility and muscle weakness. Current non-pharmacological treatments include physical therapy, orthoses and surgery. Muscle energy techniques (METs) and blood flow restriction training (BFRT) have shown promise in improving muscle function and reducing spasticity. This study aims to investigate the combined effect of MET and BFRT on upper limb motor function in patients with poststroke spasticity. Methods and analysis: This study is a single-blind randomised controlled trial involving patients with poststroke spasticity. Participants will be randomly assigned to either the MET+BFRT group or the passive stretching group. Both groups will receive conventional rehabilitation therapy, with additional MET+BFRT or passive stretching interventions. The intervention will last for 6 weeks, with four sessions per week. Primary outcomes include the simplified Fugl-Meyer assessment (FMA) and surface electromyography, while secondary outcomes include the Modified Barthel Index and the Modified Ashworth Scale. Based on literature data, patients who had a stroke have an average baseline upper limb FMA score of 40 points. Conventional rehabilitation typically improves FMA to 46 points (SD=8). This trial expects an additional 6-point improvement from the intervention. With α=0.05 (two-sided), 90% power (1−β=0.90) and 10% dropout rate, PASS V.11.0 calculation indicates a minimum requirement of 42 participants per group. Statistical analysis will be conducted using IBM SPSS Statistics V.25. Intention-to-treat analysis will be used to analyse the result, which means the last observation will be used for interpolation when data are missing. Continuous variables will be summarised as mean±SD for normally distributed data or as median and IQRs for non-normally distributed data. Categorical variables will be presented as frequencies and percentages. For continuous variables that meet the criteria of normal distribution and homogeneity of variance, two-way analysis of variance with repeated measures will be applied; for those that do not meet these criteria, the Mann-Whitney U test will be used. Categorical variables will be analysed with the χ2 test or Fisher’s exact test. Ethics and dissemination: The study protocol has been approved by the ethics committee of Jiaxing Hospital of Traditional Chinese Medicine (2024-016). Participants will provide written informed consent before inclusion. The results will be disseminated through peer-reviewed journals and conference presentations. Trial registration number: ChiCTR2400085996.


  • Open Access

    Effects of Tissue-Bone Homeostasis Manipulation at Different Time Points on Pain and Brain Mechanisms in Patients with Knee Osteoarthritis Based on Circadian Rhythm: Study Protocol for a Randomized Controlled Trial

    by Hongli Ma, Yuwu Ding, Kun Yang, Zengqiao Zhang, Haichen Xu, Wei Feng, Liming Jiang

    Background: Knee osteoarthritis (KOA) is characterized by pain and dysfunction. Tissue-bone homeostasis manipulation (TBHM) has been shown to have a good effect on KOA. However, its optimal application time and related mechanism of action are still unclear. Therefore, this study will explore the efficacy and brain mechanism of TBHM at different time points in patients with KOA. Methods: The experiment is designed as a randomized controlled single-blind study, aiming to recruit 100 patients with KOA. These patients will be divided into four groups using stratified random sampling: the TBHM group at 8 a.m. the TBHM group at 1 p.m. the TBHM group at 6 p.m. and the Joint Mobilization group. The intervention will last for 4 weeks, once a day, 5 days per week. All outcome indicators will be measured at baseline and 4 weeks after the intervention, with the efficacy indicators measured additionally during follow-up visits at the 3rd and 6th months. The efficacy results include the Visual Analog Scale, Active range of motion, SF-36, electroencephalogram (EEG) and the Hamilton Anxiety Rating Scale. The mechanism part mainly focuses on changes in melatonin content in saliva. Two-way repeated measures analysis of variance (ANOVA) will be used to measure and statistically analyze all quantitative scores, while MatLab 2022b will be utilized for the analysis of EEG data. Discussion: This study, based on “circadian rhythm”, innovatively combines different treatment times with TBHM to treat KOA pain. It will delve into the differences in the impact of this approach on KOA pain relief at different time points and clarify its potential mechanism of action. This will not only enhance the scientific understanding of the treatment effect of this manipulation but also provide new strategies and references for clinical treatment of KOA. Trial Registration: The study was registered in Chinese Clinical Trial Registry (No. ChiCTR2400080820). Registered on Feb. 07, 2024, https://www.chictr.org.cn/showproj.html?proj=220404.


  • Open Access

    Anatomy, biomechanics, and clinical advances of proximal tibiofibular joint in pain management

    by Tianjun Zhai, Fengyan Jiang, Wei Feng, Zhaohui Chen

    This article presents a descriptive review focused on the proximal tibiofibular joint (PTFJ), a synovial plane joint located posterolaterally beneath the lateral tibial plateau. The PTFJ facilitates axial load transmission, allows subtle tibiofibular motion, and works in conjunction with the distal syndesmosis to preserve ankle and knee function. Dysfunction—resulting from anatomical variation, trauma, instability, or degeneration—can lead to pain, mobility impairment, and nerve compression. Clinical conditions such as osteoarthritis and peroneal nerve entrapment are increasingly linked to PTFJ pathology. Novel therapies like proximal fibular osteotomy (PFO) have shown promise in treating medial compartment knee osteoarthritis based on the uneven settling theory. Diagnosis involves multimodal imaging, and management spans conservative, interventional, and surgical approaches. A comprehensive understanding of the PTFJ supports accurate diagnosis and the development of effective treatment strategies.